Ken Griffin Sc Pharmaceuticals Inc. Transaction History

Citadel Advisors LLC

$483 Billion
Q2 2024

A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Sc Pharmaceuticals Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 27,300 shares of SCPH stock, worth $141,687. This represents 0.0% of its overall portfolio holdings.

Number of Shares

27,300

Previous 36,300 24.79%

Holding current value

$141,687

Previous $182,000 35.16%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$3.51 - $5.21 $556,303 - $825,738	158,491 Added 27.47%	735,404 $3.2 Million
Q1 2024 May 15, 2024	BUY	$4.86 - $6.39 $2.13 Million - $2.8 Million	437,417 Added 313.57%	576,913 $2.9 Million
Q4 2023 Feb 14, 2024	BUY	$4.7 - $6.63 $632,178 - $891,774	134,506 Added 2695.51%	139,496 $874,000
Q3 2023 Nov 14, 2023	BUY	$7.0 - $9.82 $34,559 - $48,481	4,937 Added 9315.09%	4,990 $35,000
Q2 2023 Aug 14, 2023	SELL	$8.94 - $11.74 $832,036 - $1.09 Million	-93,069 Reduced 99.94%	53 $0
Q1 2023 May 15, 2023	SELL	$5.59 - $9.47 $310,725 - $526,399	-55,586 Reduced 37.38%	93,122 $844,000
Q4 2022 Feb 14, 2023	BUY	$5.38 - $7.53 $649,753 - $909,413	120,772 Added 432.32%	148,708 $1.07 Million
Q3 2022 Nov 14, 2022	SELL	$4.48 - $6.47 $86,455 - $124,858	-19,298 Reduced 40.86%	27,936 $182,000
Q2 2022 Aug 15, 2022	BUY	$4.3 - $6.48 $67,682 - $101,995	15,740 Added 49.98%	47,234 $228,000
Q1 2022 May 16, 2022	BUY	$3.9 - $6.11 $122,826 - $192,428	31,494 New	31,494 $179,000
Q3 2020 Nov 16, 2020	SELL	$7.12 - $8.86 $386,452 - $480,894	-54,277 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$7.01 - $10.96 $262,517 - $410,441	37,449 Added 222.54%	54,277 $399,000
Q2 2018 Aug 10, 2018	BUY	$5.53 - $15.4 $93,058 - $259,151	16,828 New	16,828 $0

Others Institutions Holding SCPH

# of Institutions

Shares Held

27.7M

Call Options Held

39.2K

Put Options Held

2.6K

View Full List

About scPharmaceuticals Inc.

Ticker SCPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 27,402,100
Market Cap $142M
Description
scPharmaceuticals Inc., a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is FUROSCIX that consists of formulation of furosemide, which is delivered through an on-body infusor for treatment of congestion in patients with heart failure. Its product p...

More about SCPH

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account